Image-Guided Radiation Therapy Is Equally Effective for Basal and Squamous Cell Carcinoma

Overview

Journal Dermatopathology (Basel)

Publisher MDPI

Specialty Pathology

Date 2024 Nov 25

PMID 39584849

Authors

Erin M McClure

Clay J Cockerell

Stephen Hammond

Evelyn S Marienberg

Bobby N Koneru

Jon Ward

Jeffrey B Stricker

Affiliations

Soon will be listed here.

Abstract

Non-melanoma skin cancers (NMSCs), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are highly prevalent and a significant cause of morbidity. Image-guided superficial radiation therapy (IGSRT) uses integrated high-resolution dermal ultrasound to improve lesion visualization, but it is unknown whether efficacy varies by histology. This large retrospective cohort study was conducted to determine the effect of tumor histology on freedom from recurrence in 20,069 biopsy-proven NMSC lesions treated with IGSRT, including 9928 BCCs (49.5%), 5294 SCCs (26.4%), 4648 SCCIS cases (23.2%), and 199 lesions with ≥2 NMSCs (1.0%). Freedom from recurrence at 2, 4, and 6 years was 99.60%, 99.45%, and 99.45% in BCC; 99.58%, 99.49%, and 99.49% in SCC; and 99.96%, 99.80%, and 99.80% in SCCIS. Freedom from recurrence at 2, 4, and 6 years following IGSRT did not differ significantly comparing BCC vs. non-BCC or SCC vs. non-SCC but were slightly lower among SCCIS vs. non-SCCIS ( = 0.002). There were no significant differences in freedom from recurrence when stratifying lesions by histologic subtype. This study demonstrates that there is no significant effect of histology on freedom from recurrence in IGSRT-treated NMSC except in SCCIS. These findings support IGSRT as a first-line therapeutic option for NMSC regardless of histology.

References

Yu L, Oh C, Shea C . The Treatment of Non-Melanoma Skin Cancer with Image-Guided Superficial Radiation Therapy: An Analysis of 2917 Invasive and In Situ Keratinocytic Carcinoma Lesions. Oncol Ther. 2021; 9(1):153-166. PMC: 8140015. DOI: 10.1007/s40487-021-00138-4. View

Scott J, Sedor G, Ellsworth P, Scarborough J, Ahmed K, Oliver D . Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis. Lancet Oncol. 2021; 22(9):1221-1229. DOI: 10.1016/S1470-2045(21)00347-8. View

McClure E, Sedor G, Jin Y, Kattan M . Image-guided superficial radiation therapy has superior 2-year recurrence probability to Mohs micrographic surgery. Clin Transl Radiat Oncol. 2023; 43:100678. PMC: 10539860. DOI: 10.1016/j.ctro.2023.100678. View

Aggarwal P, Knabel P, Fleischer Jr A . United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. J Am Acad Dermatol. 2021; 85(2):388-395. DOI: 10.1016/j.jaad.2021.03.109. View

Skowronek J . Brachytherapy in the treatment of skin cancer: an overview. Postepy Dermatol Alergol. 2016; 32(5):362-7. PMC: 4692821. DOI: 10.5114/pdia.2015.54746. View

Razi S, Kuo Y, Pathak G, Agarwal P, Horgan A, Parikh P . Line-Field Confocal Optical Coherence Tomography for the Diagnosis of Skin Tumors: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2024; 14(14). PMC: 11276068. DOI: 10.3390/diagnostics14141522. View

Reiter O, Mimouni I, Gdalevich M, Marghoob A, Levi A, Hodak E . The diagnostic accuracy of dermoscopy for basal cell carcinoma: A systematic review and meta-analysis. J Am Acad Dermatol. 2018; 80(5):1380-1388. DOI: 10.1016/j.jaad.2018.12.026. View

Lou B, Doken S, Zhuang T, Wingerter D, Gidwani M, Mistry N . An image-based deep learning framework for individualizing radiotherapy dose. Lancet Digit Health. 2019; 1(3):e136-e147. PMC: 6708276. DOI: 10.1016/S2589-7500(19)30058-5. View

Drucker A, Adam G, Rofeberg V, Gazula A, Smith B, Moustafa F . Treatments of Primary Basal Cell Carcinoma of the Skin: A Systematic Review and Network Meta-analysis. Ann Intern Med. 2018; 169(7):456-466. DOI: 10.7326/M18-0678. View

10.

Lomas A, Leonardi-Bee J, Bath-Hextall F . A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012; 166(5):1069-80. DOI: 10.1111/j.1365-2133.2012.10830.x. View

11.

Cives M, Mannavola F, Lospalluti L, Sergi M, Cazzato G, Filoni E . Non-Melanoma Skin Cancers: Biological and Clinical Features. Int J Mol Sci. 2020; 21(15). PMC: 7432795. DOI: 10.3390/ijms21155394. View

12.

Hurley A, Totty J, Pinder R . Dermoscopy as an adjunct to surgical excision of nonmelanoma Skin lesions: a systematic review and Meta-analysis. J Clin Aesthet Dermatol. 2022; 15(9):45-49. PMC: 9529075. View

13.

Ciazynska M, Kaminska-Winciorek G, Lange D, Lewandowski B, Reich A, Slawinska M . The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep. 2021; 11(1):4337. PMC: 7900109. DOI: 10.1038/s41598-021-83502-8. View

14.

Rogers H, Weinstock M, Feldman S, Coldiron B . Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 2015; 151(10):1081-6. DOI: 10.1001/jamadermatol.2015.1187. View

15.

Yu L, Moloney M, Tran A, Zheng S, Rogers J . Local control comparison of early-stage non-melanoma skin Cancer (NMSC) treated by superficial radiotherapy (SRT) and external beam radiotherapy (XRT) with and without dermal image guidance: a meta-analysis. Discov Oncol. 2022; 13(1):129. PMC: 9681945. DOI: 10.1007/s12672-022-00593-z. View

16.

Fionda B, Placidi E, Rosa E, Lancellotta V, Stimato G, De Angeli M . Multilayer intensity modulated contact interventional radiotherapy (brachytherapy): Stretching the therapeutic window in skin cancer. J Contemp Brachytherapy. 2023; 15(3):220-223. PMC: 10324588. DOI: 10.5114/jcb.2023.127837. View

17.

Lallas A, Argenziano G, Zendri E, Moscarella E, Longo C, Grenzi L . Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Expert Rev Anticancer Ther. 2013; 13(5):541-58. DOI: 10.1586/era.13.38. View

18.

Cameron M, Lee E, Hibler B, Barker C, Mori S, Cordova M . Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2018; 80(2):303-317. DOI: 10.1016/j.jaad.2018.03.060. View

19.

Leigh I . Progress in skin cancer: the U.K. experience. Br J Dermatol. 2014; 171(3):443-5. DOI: 10.1111/bjd.13258. View

20.

Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019; 5(12):1749-1768. PMC: 6777271. DOI: 10.1001/jamaoncol.2019.2996. View